Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors: Case report

Journal of Assisted Reproduction and Genetics

Volumn 22, Issue 3, 2005, Pages 137-140

  Kailasam, C ^a   Akande, V ^a   Gordon, U D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Contraception; Egg donor; IVF; Mirena coil

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CASE REPORT; CONTRACEPTION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; OOCYTE; OOCYTE DONATION; OVARY FOLLICLE DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; RECIPIENT; STANDARD; TREATMENT OUTCOME;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; LEVONORGESTREL; OOCYTE DONATION; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY OUTCOME;

EID: 20844433066     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-005-4889-3     Document Type: Article

References (15)

1. Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM: Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 2004;19(7):1544-1547
2. Human Fertilisation and Embryology Authority: Code of Practise, 6th edition. London, UK, 2003
3. Lahteenmaki P, Rauramo I, Backman T: The levonorgestrel intrauterine system in contraception. Steroids 2000;65:693-697
4. Victor EW, Johansson EDB: Sex hormone binding globulin: the carrier protein for d-norgestrel. J Clin Endocrinol Metab 1976;43:244-247
5. Nilsson CG, Lähteenmäki P, Luukkainen T, Robertson DN: Sustained intrauterine release of levonorgestrel over five years. Fertil Steril 1986;45:805-807
6. Luukkainen T, Toivonen J: Levonorgestrel releasing IUD as a method of contraception with therapeutic properties. Contraception 1995;52:269-276
7. Silverg SG, Haukkamaa M, Arko H: Endometrial morphology during long-term use of Levonorgestrel releasing intrauterine devices. Intl J Gynecol Pathol 1986;5(3):235-241
8. Nilsson CG, Lahteenmaki PLA, Luukkainen T: Ovarian function in amenorrhoeic and menstruating users of a levonorgestrel releasing intrauterine device. Fertil Steril 1984;41:52
9. Xiao B, Zeng T, Shangchun W, Hongzhu S, Xiao N: Effect of levonorgestrel releasing intrauterine device on hormonal profile and menstrual pattern after long-term use. Contraception 1995;51:359-365
10. Luukkainen T, Pakarinen P, Toivonen J: Progestin releasing intrauterine systems. Seminars in Reproductive Medicine 2001;19(4):355-363
11. Luukkainen T, Lahteenmaki P, Toivonen J: Levonorgestrel - releasing intrauterine device. Ann Med 1990;22:85-90
12. Barbara S, Bundren JC: Effects of levonorgestrel on capacity of mouse oocytes for fertilisation and development. Contraception 1995;51:209-214
13. Alvarez F, Brache V, Tejada AS, Faundes A: Abnormal endocrine profile among women with confirmed or presumed ovulation during long term Norplant use. Contraception 1986;33(2):111-119
14. Alvarez F, Brache V, Faundes A, Tejada AS, Thevenin F: Ultrasonographic and Endocrine evaluation of Ovarian Function among Norplant Implants Users with regular menses. Contraception 1996;54:275-279
15. Horacio BC: Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 2002;65;1:21-27